| Date | Title | Description |
| 02.09.2026 | Thermo Fisher Ships EMPAD G2: Detector That Broke Atomic Imaging Records | By Katie Osborne
Published: Sep 02 2026, 10:33 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 24.08.2026 | Personalized mRNA Cancer Vaccine Clears Phase 3: Melanoma Recurrence Cut by Half | By Joseph Blake
Published: Aug 24 2026, 11:46 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 12.08.2026 | Skylark Bio Doses First Child With GJB2 Gene Therapy, No Treatment Has Ever Existed | By Donald C. Case
Published: Aug 12 2026, 2:32 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 11.08.2026 | AI Agents Beat Chemical Giants’ Chip-Heat Formulations in 90 Days, Startup Says | By Daniel Butler
Published: Aug 11 2026, 1:54 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 11.08.2026 | Aureka Open-Sourced Antibody AI That Beats AlphaFold 3; Closes $100M Drug Discovery Round | By Earl Bensen
Published: Aug 11 2026, 10:47 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 10.08.2026 | AWS Engineers Move Into Novo Nordisk Lab as Bio Discovery Cuts Coding Barrier | By Brandon Fisher
Published: Aug 10 2026, 1:15 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 07.08.2026 | Japan’s Ono Pharmaceutical Funds Fibrosis Discovery After Lilly’s $99M Bet on Same Biotech | By Morris Robinson
Published: Aug 07 2026, 1:47 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 06.08.2026 | mFLUSIVA Approved: FDA Clears mRNA Flu Shot, Unlocking Combo and Pandemic Vaccine Resubmission | By Clayton Lewis
Published: Aug 06 2026, 8:17 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 05.08.2026 | Icotyde Has Only 90 Days of Sales History When Cavanaugh Takes J&J’s Helm | By Benjamin Eddie
Published: Aug 05 2026, 12:52 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 04.08.2026 | Pathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials | By James Whitaker
Published: Aug 04 2026, 3:03 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 31.07.2026 | In Vivo CAR-T’s Liver Problem Now Has Targeted Answer: CREATE Acquires Monash’s 8-Fold LNP Fix | By Benjamin Eddie
Published: Jul 31 2026, 1:14 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 31.07.2026 | Moderna Norovirus Vaccine Fails Interim Bar: Trial Extends Into Fourth Season | By Collin Mercer
Published: Jul 31 2026, 9:16 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 30.07.2026 | FDA Panel Rejects Deramiocel Evidence as Lancet Validates Same Trial Data | By Alfredo Hanson
Published: Jul 30 2026, 3:07 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 30.07.2026 | GSK Backs Relation Therapeutics With $110M to Build Biological Data Factory | By James Whitaker
Published: Jul 30 2026, 10:00 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 30.07.2026 | Botulinum Toxin Wins First FDA Clearance to Test Frown-Muscle Theory of Depression | By Joseph Blake
Published: Jul 30 2026, 11:40 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 20.07.2026 | Viral Immunotherapy Gets FDA Fast Track for Anal Cancer Patients Without Options | By Earl Bensen
Published: Jul 20 2026, 4:16 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.07.2026 | Tau Therapy Slows Alzheimer’s Decline in First Human Trial as AAIC 2026 Wraps in London | By Ronald Holman
Published: Jul 15 2026, 11:50 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 14.07.2026 | Alzheimer’s Tau Drug Slows Cognitive Decline and Cuts Brain Tangles in Trial | By Russell White
Published: Jul 14 2026, 4:14 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 14.07.2026 | FDA Finalizes Psychedelic Trial Rules: Unblinding Problem Gets Official Answer | By Philip Nickell
Published: Jul 14 2026, 2:21 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 13.07.2026 | Alzheimer’s Drug Targets Astrocytes, Not Amyloid: Pepinemab Advances to Phase 2b | By Mike Gonzales
Published: Jul 13 2026, 10:10 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 10.07.2026 | Alzheimer’s Conference Opens Sunday as Lecanemab’s Real-World Test Arrives | By Mike Gonzales
Published: Jul 10 2026, 4:21 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 06.07.2026 | Doctor Who Faces Its Most Uncertain Future as BBC Competitive Tender Begins | By William Chan
Published: Jul 06 2026, 1:00 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 24.06.2026 | Genetic Heart Disease Has No Approved Cure: Merck KGaA Bets $50M on Gene Modulation Startup | By Chase Fiorini
Published: Jun 24 2026, 11:08 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 17.06.2026 | Type 1 Diabetes in Children: FDA Approves Tzield to Slow Immune Attack After Diagnosis | By Maxwell Templeton
Published: Jun 17 2026, 13:49 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 16.06.2026 | Thyroid Eye Disease Treatment: MHB018A Subcutaneous Shot Hits 81% Proptosis Response | By Maxwell Templeton
Published: Jun 16 2026, 08:58 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 16.06.2026 | Oral Osteoporosis Drug Clears Key PK Test: Pill Matching Forteo Heads to Phase 3 Trial | By Maxwell Templeton
Published: Jun 16 2026, 13:10 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.06.2026 | CAH Drug Atumelnant Cut Androgens 67% While Ending Decades of Steroid Overload | By John Bright
Published: Jun 15 2026, 14:41 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.06.2026 | Oral Acromegaly Pill PALSONIFY Sustains Two-Year IGF-1 Control in New ENDO Data | By Chase Fiorini
Published: Jun 15 2026, 10:12 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 11.06.2026 | Colon Cancer Immunotherapy Wins FDA Priority Review: Tecentriq Cuts Recurrence Risk 50% | By Maxwell Templeton
Published: Jun 11 2026, 13:39 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 10.06.2026 | Atopic Dermatitis Treatment EBGLYSS Cuts Injections to 6 Per Year After FDA Approval | By Maxwell Templeton
Published: Jun 10 2026, 13:39 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 08.06.2026 | Pfizer Berobenatide ADA Data: Monthly Dosing Aims at Wegovy, but Weight Loss Trails Zepbound | By Maxwell Templeton
Published: Jun 08 2026, 11:36 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 06.06.2026 | Synchron Brain Implant Targets 2026 Pivotal Trial for First FDA-Approved BCI | By Richard L. Wells
Published: Jun 06 2026, 21:54 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 29.05.2026 | Inhaled Insulin for Children: FDA Reaches Decision Deadline for Afrezza | By Shannon Harwood
Published: May 29 2026, 07:06 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 19.05.2026 | Trump bought stock in drugmaker as his government boosted its obesity drugs | Getting your Trinity Audio player ready...
By Darius Tahir, KFF Health News
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees under... |
| 24.03.2026 | Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study | Developing solutions to improve quality of life after menopause
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization
Suffering with vaginal dryness and sexual pain is completely unnecessary. With th... |
| 16.03.2026 | Конвейер деторождения, мозг мыши за штурвалом и другие новости с переднего края биотеха | Приветствую, читатели! Это свежие заметки о жизни на пороге сингулярности. Меня зовут Игорь Santry, я техноредактор. Я завёл эту колонку, чтобы собрать лучшие лонгриды и видео, которые зацепили меня за последнее время.
Этот выпуск тематичес... |
| 10.01.2026 | 2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market | In 2026, new obesity pills will push the booming GLP-1 market into its next chapter.
Pills may serve as a more convenient — and in certain cases cheaper — alternative to today’s blockbuster injections that could attract entirely new patient... |
| 29.12.2025 | Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC "Blockbuster" Therapy | TAIPEI and SAN DIEGO, Dec. 29, 2025 /PRNewswire/ -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging... |
| 15.12.2025 | Нобелевская премия-2025: кто главные бенефициары научных открытий ученых-лауреатов? | Нобелевскую премию вручают за самые передовые открытия — и, конечно, у них есть большой коммерческий потенциал. Право авторства и право на саму разработку — это несколько разные вещи, и возможность получить действительно высокую прибыль буд... |
| 03.12.2025 | Top Startup and Tech Funding News – December 3, 2025 | It’s Wednesday, December 3, 2025, and we’re back with the top startup and tech funding news stories spanning longevity biotech, AI-native agents, construction automation, crypto finance, encrypted data infrastructure, and synthetic biology.... |
| 01.12.2025 | Protego plans pivotal trial for AL amyloidosis prospect with $130M series B | Protego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new $130 million series B fundraise.
The oversubscribed funding round, led by Novartis Venture Fund and Forbion, picke... |
| 20.11.2025 | Top Tech News Today, November 20, 2025 | Top Tech News Stories Today — Your Quick Briefing on the Latest Technology News, Global Innovation, and AI-Driven Shifts Reshaping the Future
It’s Thursday, November 20, 2025, and we’re back with your in-depth look at the most important dev... |
| 25.08.2025 | Exclusive: Safe, Direct-to-Brain Autologous Stem Cell Therapy Shows Promise in Alzheimer’s | A Phase 1, "first-in-mankind" trial of stem cells injected directly into the brain, is safe with early signs of efficacy; FDA submission made for Phase 2 trial. NEWPORT BEACH, CA, UNITED STATES, August 25, 2025 /EINPresswire.com/ ... |
| 07.08.2025 | US NCI Sponsors Senhwa Biosciences' Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma | TAIPEI and SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that US N... |
| 18.07.2025 | Vested interests. Influence muscle. At RFK Jr.’s HHS, it’s not pharma. It’s wellness | The total doesn’t include revenue from speaking fees, the sale of wellness products, or other income sources for which data isn’t publicly available.
The Means siblings have launched wellness companies that have raised more than $99 million... |
| 16.07.2025 | Chronic Urticaria Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast | Chronic Urticaria Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast
The chronic urticaria epidemiology report provides a detailed analysis of the current marketed drugs and late-stage pipeline drugs. BROOKLYN, NY... |
| 16.07.2025 | Hernia Market Epidemiology Report | Size, Share, Growth Opportunity 2025-2035 | Hernia Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 BROOKLYN, NY, UNITED STATES, July 16, 2025 /EINPresswire.com/ -- The 7 major hernia markets are expected to exhibit a CAGR of 2.18% ... |
| 16.07.2025 | Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast | Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast
The report provides a detailed analysis of the current age-related macular degeneration marketed drugs and late-stage pipeline dr... |
| 16.07.2025 | Chronic Pain Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast | Chronic Pain Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast
The report provides a detailed analysis of the current chronic pain marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 1... |
| 14.07.2025 | Genital Herpes Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, and Regional Outlook | Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035
The report provides a detailed analysis of the current genital herpes marketed drugs and late-stage pipeline drugs. BROOKLYN... |
| 10.07.2025 | Paris-based FemTech app Solence raises €1.6 million to address PCOS with AI-driven digital therapeutics | French startup Solence, an app that helps women suffering from Polycystic Ovary Syndrome (PCOS), has raised €1.6 million in Seed funding to deepen product functionality and expanding the team.
This round included Impact Shakers Ventures, an... |
| 20.06.2025 | Nuclear Medicine Market Set to Witness Significant Growth by 2025-2032 | Siemens Healthineers, GE Healthcare, Philips | Nuclear Medicine Market BURLINGAME, CA, UNITED STATES, June 20, 2025 /EINPresswire.com/ --
The Global Nuclear Medicine Market is estimated to be valued at USD 18.32 Bn in 2025 and is expected to reach USD 38.52 Bn by 2032, exhibiting a comp... |
| 19.06.2025 | Immunotherapy Drugs Market Outlook 2025–2032: Growing Applications in Oncology to Drive beyond USD 398.16 Bn by 2032 | Immunotherapy Drugs Market Growth 2025 BURLINGAME, CA, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- Global Immunotherapy Drugs Market is estimated to be valued at USD 185.72 Bn in 2025 and is expected to reach USD 398.16 Bn by 2032, e... |
| 06.06.2025 | Top 10 Startup and Tech Funding News for the Week Ending June 6, 2025 | It’s Friday, June 6, 2025—and we’re wrapping up the week with your daily tech funding snapshot, spotlighting where capital is flowing and which startups are gearing up for their next leap.
Today’s lineup features a wide-ranging mix of start... |
| 30.05.2025 | Top Startup and Tech Funding News for the Week Ending May 30, 2025 | It’s Friday, May 30, 2025—and this wraps up our tech funding coverage for both the week and the month of May.
Today’s lineup features a diverse mix of AI, biotech, fintech, healthtech, and industrial startups closing fresh capital to scale ... |
| 20.05.2025 | Biotechnology Market Set to Witness Significant Growth by 2025-2032 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline | Biotechnology Market Growth 2025 BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting a comp... |
| 16.05.2025 | Ketorolac Market Key Players Analysis -Allergan plc, Deepcare Health Pvt Ltd, Cadila Healthcare, Intas Pharmaceuticals | Ketorolac Market Growth 2025 BURLINGAME, CA, UNITED STATES, May 16, 2025 /EINPresswire.com/ --
Qualitative latest Research report (2025-2032) on the Ketorolac Market by Coherent Market Insights Provides a deep dive into key market trends, d... |
| 16.05.2025 | US Cannabis Testing Services Market Size to Reach USD 4.71 Bn, Globally by 2032 at 12.7% CAGR: Coherent Market Insights | US Cannabis Testing Services Market Growth 2025 BURLINGAME, CA, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- US cannabis testing services market is estimated to be valued at USD 2.04 Bn in 2025 and is expected to reach USD 4.71 Bn by 2... |
| 16.05.2025 | Polycystic Ovary Syndrome (PCOS) Treatment Market Size to Reach US$ 1,666.1 Mn by 2032, Reports Coherent Market Insights | Polycystic Ovary Syndrome (PCOS) Treatment Market BURLINGAME, CA, UNITED STATES, May 15, 2025 /EINPresswire.com/ --
The latest report (2025-2032) on the Polycystic Ovary Syndrome (PCOS) Treatment Market by Coherent Market Insights Provides ... |
| 16.05.2025 | Global Pharmaceutical Contract Sales Outsourcing (CSO) Market in 2025 Detailed Study Analysis | Coherent Market Insights | Global Pharmaceutical Contract Sales Outsourcing (CSO) Market BURLINGAME, CA, UNITED STATES, May 16, 2025 /EINPresswire.com/ --
The global pharmaceutical contract sales outsourcing (CSO) market size is expected to reach US$ 19,362.4 Mn by 2... |
| 13.05.2025 | Health Coach Market Projected To Witness Massive Growth, 2025-2032 | Noom, Inc., HealthifyMe, Omada Health, Iora Health | Health Coach Market Growth 2025 BURLINGAME, CA, UNITED STATES, May 12, 2025 /EINPresswire.com/ --
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compo... |
| 12.05.2025 | Ambulatory Infusion Center Market Set to Witness Significant Growth by 2025-2032 | Option Care Health, Inc., CVS Health | Ambulatory Infusion Center Market report 2025 BURLINGAME, CA, UNITED STATES, May 12, 2025 /EINPresswire.com/ --
The global ambulatory infusion center market is estimated to be valued USD 52.19 Bn in 2025 and is expected to reach USD 107.07 ... |
| 31.03.2025 | Traws Pharma Reports Full Year 2024 Results and Business Highlights | Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data
Ongoing FDA interaction to align on path forward for t... |
| 21.03.2025 | Zepbound copycats remain online despite FDA ban | Compounding pharmacies were largely supposed to stop making versions of tirzepatide this week, but it's still available on some popular websites like Amble, EllieMD, Willow and Mochi Health.
Pharmacies were able to make copycat versions of ... |
| 03.03.2025 | Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media | Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media
Mon, Mar 03, 2025 07:00 CET Report this content
More than 50 articles and interviews featuring Circi... |
| 22.01.2025 | Chain Nursing Home Market Set to Witness Significant Growth by 2025-2032:Taikang Home, Yihua Healthcare, Merrill Gardens | Chain Nursing Home Market BURLINGAME, CA, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Chain Nursing Home Market Trends Overview 2025-2032:
A new Report by Coherent Market Insights, titled "Chain Nursing Home Market: Industry ... |
| 22.01.2025 | Cryo-Electron Microscopy (Cryo-EM) Market Set to Witness Significant Growth by 2025-2032: Olympus Corporation, OPTIKA | Cryo-Electron Microscopy (Cryo-EM) Market BURLINGAME, CA, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Cryo-Electron Microscopy (Cryo-EM) Market Trends Overview 2025-2032:
A new Report by Coherent Market Insights, titled "Cryo... |
| 22.01.2025 | Healthcare Physician Staffing Market Projected To Witness Substantial Growth 2025-2032:Interim HealthCare Inc,Mdstaffers | Healthcare Physician Staffing Market Trend 2025 BURLINGAME, CA, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Healthcare Physician Staffing Market Trends Overview 2025-2032:
A new Report by Coherent Market Insights, titled "Hea... |
| 22.01.2025 | Outpatient Oncology Infusion Market Projected To Witness Substantial Growth, 2025-2032:Nipro Corporation, Fresenius Kabi | Outpatient Oncology Infusion Market BURLINGAME, CA, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Outpatient Oncology Infusion Market Trends Overview 2025-2032:
A new Report by Coherent Market Insights, titled "Outpatient Oncol... |
| 16.01.2025 | Social Determinants of Health Market Set to Witness Significant Growth by 2025-2032: Orion Health, Signify Health | Social Determinants of Health Market 2025
social determinants of health (SDOH) market size is expected to reach US$ 18.06 Bn by 2030, from US$ 5.57 Bn in 2023, exhibiting a CAGR of 18.3%. BURLINGAME, CA, UNITED STATES, January 15, 2025 /EIN... |
| 16.01.2025 | Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, Illumina, Inc | Biomarker Research Services Market 2025
Biomarker Research Services Market is estimated to be valued at USD 6.81 Bn in 2024 and is expected to reach USD 191.10 Bn by 2031, exhibiting a CAGR of 61%. BURLINGAME, CA, UNITED STATES, January 15,... |
| 16.01.2025 | Herpes Simplex Virus (HSV) Vaccines Market Set to Witness Significant Growth by 2025-2032:Sanofi S.A,GlaxoSmithKline Plc | Herpes Simplex Virus (HSV) Vaccines Market 2025
Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts. BURLINGAME, CA, UNITED STATES, January ... |
| 16.01.2025 | Real World Data (RWD) Market Projected To Witness Substantial Growth, 2025-2032: IBM Corporation, Tempus Labs Inc | Real World Data (RWD) Market Size 2025
Real World Data (RWD) Market size is projected to grow from US$ 1.59 Bn in 2023 to US$ 4.07 Bn by 2030, at a CAGR of 14.4%. BURLINGAME, CA, UNITED STATES, January 15, 2025 /EINPresswire.com/ -- Latest ... |
| 16.01.2025 | Medical Metal Tubing Market Set to Witness Significant Growth by 2025-2032: Tech Tube, Inc, Vita Needle Company | Medical Metal Tubing Market 2025
medical metal tubing market is estimated to be valued at US$ 704.2 mn in 2023 and is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030) BURLINGAME, CA, UNITED STATES, January 15, 2025 ... |
| 16.01.2025 | Home Healthcare Market Set to Witness Significant Growth by 2025-2032:Kindred Healthcare, LHC Group, Amedisys,AccentCare | Home Healthcare Market 2025
Home Healthcare Market is estimated to be valued at USD 401.10 Bn in 2024 and is expected to reach USD 702.11 Bn by 2031, exhibiting a CAGR of 8.3%. BURLINGAME, CA, UNITED STATES, January 15, 2025 /EINPresswire.c... |
| 16.01.2025 | Tissue Plasminogen Activator Market Projected To Witness Substantial Growth, 2025-2032: Gennova Biopharmaceuticals Ltd | Tissue Plasminogen Activator Market 2025
Tissue Plasminogen Activator Market is estimated to be valued at US$ 2.58 Bn in 2023, and is expected to exhibit a CAGR of 5.2% by (2023-2030). BURLINGAME, CA, UNITED STATES, January 15, 2025 /EINPre... |
| 16.01.2025 | Electronic Medical Records Market Projected To Witness Substantial Growth, 2025-2032: McKesson Corporation, Oracle | Electronic Medical Records Market 2025
Electronic Medical Records Market is estimated to be valued at USD 31.58 Bn in 2024 and is expected to reach USD 46.37 Bn by 2031, exhibiting a CAGR of 5.6%. BURLINGAME, CA, UNITED STATES, January 15, ... |
| 16.01.2025 | Value-Based Healthcare Market Set to Witness Significant Growth by 2025-2032:Athena Healthcare, Curation Health,Deloitte | Value-Based Healthcare Market Size 2025
value-based healthcare market was valued at US$ 12.18 Bn in 2023 and is expected to reach US$ 43.39 Bn by 2031, growing at a CAGR of 17.2% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, January 15,... |
| 20.11.2024 | Genetic Testing Delivers Startup Hits And Misses | 3 Shares Email Facebook Twitter LinkedIn
When submitting a genetic test, one usually has a desired outcome in mind. That doesn’t mean the results will bear it out.
Investing in DNA testing startups is much the same. Over the years, startup ... |
| 12.11.2024 | Syner-G BioPharma Group Recognized as a 2025 Best Place to Work by BioSpace | Syner-G BioPharma
For commitment to fostering a supportive, innovative, and inclusive work environment
BOSTON, Nov. 12, 2024 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group, a leading provider of regulatory strategy, product development, and ... |
| 24.10.2024 | Transcranial Magnetic Stimulator Market Projected To Witness Substantial Growth, 2024-2031:Nexstim Plc, Neuronetics, Inc | Transcranial Magnetic Stimulator Market Size 2024
Transcranial Magnetic Stimulator Market size is expected to reach US$ 1,447.1 Mn by 2031 from US$ 638.4 Mn in 2024 at a CAGR of 12.4% during the forecast period BURLINGAME, CA, UNITED STATES... |
| 24.10.2024 | Antiparasitic Drugs Market Set for Rapid Growth and Trend by 2024-2031 Key Drivers And Analysis – Aurobindo Pharma | Antiparasitic Drugs Market
Global Antiparasitic Drugs Market is estimated to be valued at US$ 23.40 billion in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period BURLINGAME, CA, UNITED STATES, October 24, 2024 /EINPre... |
| 19.09.2024 | 3 Genomics Stocks Transforming Healthcare Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investin... | Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals (REGN), Al... |
| 16.07.2024 | Walking the Talk of Patient-Centricity in Cell and Gene Therapy Trials | JEEVA PRS 3
Remarkable progress in the development of cell and gene therapies (CGTx) has ignited hope for millions of patients battling debilitating human diseases including Central Nervous System (CNS) and neuromuscular diseases. However, ... |
| 25.06.2024 | Circio´s leading position in circular RNA therapeutics highlighted by broad recent coverage in international life science industry media | Circio´s leading position in circular RNA therapeutics highlighted by broad recent coverage in international life science industry media
Tue, Jun 25, 2024 07:00 CET Report this content
Circio´s position as a pioneering player in the rapidly... |
| 24.06.2024 | Abrasives Market Size to Reach $64.90 Billion Globally by 2030: Latest Report by Vantage Market Research | Vantage Market Research
Abrasives Market Size to Grow by $64.90 Bn | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, June 24, 2024 /EINPresswire.com/... |
| 24.06.2024 | Advanced Composites Market Size to Reach $58.48 Billion Globally by 2030: Latest Report by Vantage Market Research | Vantage Market Research
Advanced Composites Market Size to Grow by $58.48 Bn | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, June 24, 2024 /EINPres... |
| 19.06.2024 | ElevateBio: компания по производству генетических лекарств | Содержание
История компании
Технологии: объединение производства и некстген технологий терапевтического производства
Экосистема компании
BaseCamp
Партнеры
Отраслевые партнерства
Академические партнерства
Привлечение инвестиций История компа... |
| 17.06.2024 | Pharma 4.0 Market Size to Reach $61 Billion Globally by 2032: Latest Report by Vantage Market Research | Vantage Market Research
Pharma 4.0 Market Size to Grow by $61 Bn | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, June 17, 2024 /EINPresswire.com/ -... |
| 13.06.2024 | Blockchain in Healthcare Market Size to Reach $20976.96 Million by 2030: Latest Report by Vantage Market Research | Vantage Market Research
Blockchain in Healthcare Market Size to Grow by $20976.96 Mn | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, June 13, 2024 ... |
| 25.04.2024 | Bay Area leads in "femtech" growth potential | figcaption>span]:font-sans">
The Bay Area "femtech" sector — focused on technological products and services tailored toward women's health — has grown substantially in the last few years amid broader challenges in the t... |
| 16.03.2024 | The hunt for long COVID answers zeroes in on causes | Researchers are getting closer to understanding the underlying causes of long COVID and potential ways to definitively test for it.
Why it matters: That would be a massive step toward unlocking a complex condition that's debilitated million... |
| 09.03.2024 | Founder and CEO of Dark Horse Talent, Bryan Wells, Featured in Planet BioSpace | PLANO, TX, USA, March 8, 2024 /EINPresswire.com/ -- Founder and CEO of Dark Horse Talent – A member of the Sanford Rose Associates® network of offices, Bryan Wells, Featured in Planet BioSpace, Data Analysts Take on Greater Role Amid Data E... |
| 09.02.2024 | Does Moderna’s RSV vaccine lose efficacy faster than others? | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a li... |
| 29.01.2024 | These are the 7 healthcare startups primed to IPO when the market reopens | Premium Tech These are the 7 healthcare startups primed to IPO when the market reopens
Rebecca Torrence
2024-01-29T10:00:01Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It in... |
| 25.01.2024 | Key Trends from the 2024 J.P. Morgan Healthcare Conference | Beneath the Californian sunshine (and a few showers) at JP Morgan, a revolution simmers. Not a political one, but a healthcare revolution propelled by necessity and fueled by innovation. Imagine a future where groundbreaking therapies reach... |
| 21.12.2023 | CRISPR, генная и клеточная терапия: краткая история прорывных технологий | Многие заболевания и серьезные нарушения можно исправить, если вмешаться в генетический код человека. Это и генетические заболевания, включая врожденные пороки, слепоту и т. д, и последствия мутации клеток, такие как онкология, и даже лечен... |
| 07.12.2023 | In pigs, researchers show ultrasound could be used for 3D printing inside the body | Imagine getting surgery without ever being cut open. Researchers at Duke University and Harvard Medical School have successfully demonstrated a proof of concept in new research published Thursday in Science using a 3D printer that uses ultr... |
| 04.12.2023 | Navigating Air Pollution and the Rise in Respiratory Issues During Winter | The onset of the winter season brings its own set of challenges to respiratory health, as air pollution continues to be an undeniable reality impacting our daily lives and breathing. In recent times, the world has witnessed the negative eff... |
| 11.10.2023 | HealthTech Arkansas Cohort Companies in the News | 2022 cohort company Echo IQ has partnered with Cassling, a company that will act as a sales agent for Echo IQ’s EchoSolv software. EchoSolv is a proprietary artificial intelligence clinical decision support platform that supports cardiology... |